Summary & Overview
HCPCS J0710: Injection, Cephapirin Sodium, Up to 1 gm
HCPCS Level II code J0710 identifies the parenteral administration of cephapirin sodium, up to 1 gram per dose. As an HCPCS Level II drug code, it is used on professional and institutional claims when this specific injectable antibiotic is supplied and administered. The code matters nationally because it standardizes reporting for acquisition, administration, and reimbursement of a specific parenteral antibiotic across outpatient and facility settings.
This publication covers coverage and billing considerations across major payers, including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of where and how the code is typically used, payer coverage scope, and common billing modifiers (listed separately). The analysis highlights typical sites of service for J0710, clinical context for parenteral antibiotic use, and the administrative reporting expectations associated with HCPCS Level II drug codes.
Readers will learn practical benchmarks and policy-relevant items: how J0710 is recorded on claims, which payer types commonly process it, and the documentation elements that support its use. Where input data is incomplete, the publication notes those gaps explicitly. The goal is to provide a clear national-level summary for clinicians, coding professionals, and revenue cycle staff responsible for correctly reporting injectable antibiotic therapy.
Billing Code Overview
HCPCS Level II code J0710 describes an injection of cephapirin sodium, up to 1 gm. This code represents a single-dose parenteral administration of the antibiotic cephapirin sodium.
-
Service type: Injectable antibiotic administration
-
Typical site of service: Outpatient clinic, physician office, hospital outpatient department, or other outpatient infusion/administration settings
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 62-year-old male presenting to an outpatient infusion center or hospital inpatient ward with a postoperative wound infection following orthopedic surgery (e.g., infected joint prosthesis) or a severe community-acquired skin and soft tissue infection where parenteral beta-lactam therapy is indicated. The clinician orders J0710 (injection, cephapirin sodium, up to 1 gm) for intravenous administration. Nursing verifies allergy history (notable for penicillin or cephalosporin allergy), obtains baseline vital signs and renal function, prepares the dose per pharmacy reconstitution guidelines, and administers via IV push or infusion depending on institutional policy. The workflow includes documentation of indication, dose, lot number, route, site of administration, and any immediate adverse reactions. For inpatient surgical prophylaxis, J0710 may be administered preoperatively in the operating room or perioperatively in the pre-op area by anesthesia or nursing staff. For outpatient infusion, the patient is observed post-administration for infusion reactions before discharge or return to inpatient care.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required to prepare or administer the injection is substantially greater than typical (rare for standard single-dose injections). |